Quoin Pharmaceuticals, Ltd. Stock Prediction and Forecast [QNRX]

AI-generated source summary

The analysis indicates that Quoin Pharmaceuticals (QNRX) has been ranked as a buy candidate since September 12, 2025, with a score of 3.8. The stock has gained approximately 7.98% since then, averaging a 2.66% daily return. The stock has broken its short-term falling trend, indicating a potential trend shift upwards. Support is expected at $7.90, potentially offering a second buy opportunity. According to fan theory, the next peak level is $10.08. The three-month trend suggests a potential change of -20.42% with a possible return between -44.59% and -23.4%. The 12-month analysis anticipates a 201.98% change, putting the future price between $18.22 and $48.75. The latest daily update shows a green day with a 4.94% gain to $8.21. Analyst ratings suggest a strong sell on return on equity and a neutral position for price to book value.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   17 Sept 2025, 03:28 UTC

   The analyst published the original source item.

2. First prediction resolved

   22 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   22 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.